Published: February 2023
According to a recently published report by Roots Analysis, the growing development pipeline and encouraging clinical trial results is driving the TIL therapy market growth
The global TIL therapy market is anticipated to grow at a CAGR of 40% from 2023-2035, reaching USD 5 billion by 2035.
Tumor infiltrating lymphocytes (TILs) constitute a diverse group of mononuclear lymphocytes, encompassing T-cells, B-cells, NK cells, and macrophages isolated from the tumor environment. Therapies utilizing TILs involve the retrieval of these cells from tumor specimens, followed by in vitro expansion with the aid of IL-2, a growth factor. The expanded autologous TILs are subsequently reintroduced into the respective cancer patients. Once in the host, these cells play a crucial role in eliminating tumor cells, and their capacity to form a memory response allows them to target recurring tumors. Importantly, such therapies often do not necessitate special interventions to maintain immunological memory persistence.
Browse 120+ figures and 135+ market data tables spread across 285+ pages and detailed Table of Content on “ TIL Therapy Market by Distribution by Target Indication, Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/til-therapies-market.html
Several factors are propelling the growth of the TIL therapy market. The increasing prevalence of cancer cases is driving the demand for tumor infiltrating lymphocyte therapies / TIL therapies, consequently propelling market growth. Further, the ongoing and planned clinical research initiatives in this domain are driven by encouraging results achieved in past trials, which were mostly focused on various solid tumors. Additionally, owing to the ongoing pace of innovation in this field, sufficient financial support from investors and encouraging clinical trial results, the demand for TIL therapies is also expected to witness a significant rise.
While the TIL therapy market is experiencing substantial growth, it is not without its challenges. One of the primary restraints is the high cost associated with the development of these therapies. This has led to an increase in the overall cost of TIL therapies and low patient adoption. Additionally, no TIL based therapy has yet been approved till now. These factors are expected to hinder the growth of this market in the coming years.
Despite the challenges, several growth factors continue to drive the TIL therapy market forward. One notable factor is the polyclonal nature of these therapies which allows them to simultaneously recognize and attack more than one target. The chances of eliminating cells bearing tumor-specific antigens are high when TILs are used, thereby making the treatment more robust. Owing to their tumor-killing capability and therapeutic superiority, TIL therapies are being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders. Driven by several advantages and growth factors, TIL therapy market is likely to carve out a significant share of the multi billion-dollar cancer immunotherapy market.
The TIL therapy market report also includes detailed profiles of key players (listed below) that develops tumor infiltrating lymphocytes therapies:
Several recent developments have taken place in the TIL therapy market. We have covered some of these recent initiatives below. These developments, even though they took place after the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
You Can Download Free Sample PDF Copy of This Report At:
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES